Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03219541 · ClinicalTrials.gov registry record · NA
Feasibility and Acceptability of a Text Messaging Intervention to Increase Smoking Cessation in Vietnam
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 190
- Enrollment target
NCT03219541: Completed NA study, sponsored by NYU Langone Health.
NCT03219541 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 190 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03219541, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and then test the feasibility, acceptability, and preliminary effect of a bidirectional text message smoking cessation intervention among Vietnamese smokers in Hanoi, Vietnam. The specific aim are: 1) To develop a smoking cessation text message library among Vietnamese smokers; 2) To evaluate message preferences, and the feasibility and acceptability of the bidirectional text message smoking cessation intervention; and 3) To assess the preliminary effect of a bidirectional mobile phone text message intervention on biochemically validated smoking abstinence.
Primary Outcome
Measured by ranking the mean score of each message
Interventions
- BEHAVIORAL Interventional Automated mobile phone text
- BEHAVIORAL Control Automated mobile phone text
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2018-02-05 |
| Est. Completion | 2019-03-13 |
| Phase | NA |
What the finished NCT03219541 record still lists
NCT03219541 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which Interventional Automated mobile phone text is the first listed.
NCT03219541 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03219541 about?
NCT03219541 is a clinical study titled "Feasibility and Acceptability of a Text Messaging Intervention to Increase Smoking Cessation in Vietnam". The purpose of this study is to develop and then test the feasibility, acceptability, and preliminary effect of a bidirectional text message smoking cessation intervention among Vietnamese smokers in Hanoi, Vietnam. The specific aim are: 1) To develop a smoking cessation text message library among V...
What is the current status of trial NCT03219541?
This trial is currently completed. It is a NA study. The enrollment target is 190 participants. The study started on 2018-02-05. Estimated completion is 2019-03-13.
What interventions are being tested in trial NCT03219541?
The interventions under investigation include: Interventional Automated mobile phone text (BEHAVIORAL), Control Automated mobile phone text (BEHAVIORAL).
Who is sponsoring clinical trial NCT03219541?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03219541's enrollment target sits among peer trials
190 574th of 2000 higher than 1,425 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI